Mark R. Fleisher

2.0k total citations · 1 hit paper
17 papers, 1.2k citations indexed

About

Mark R. Fleisher is a scholar working on Genetics, Surgery and Immunology. According to data from OpenAlex, Mark R. Fleisher has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 6 papers in Surgery and 6 papers in Immunology. Recurrent topics in Mark R. Fleisher's work include Inflammatory Bowel Disease (11 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Eosinophilic Esophagitis (3 papers). Mark R. Fleisher is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Eosinophilic Esophagitis (3 papers). Mark R. Fleisher collaborates with scholars based in United States, Canada and Spain. Mark R. Fleisher's co-authors include Brian G. Feagan, Marion Blank, Richard N. Fedorak, William J. Sandborn, Ellen Scherl, Paul Rutgeerts, Jewel Johanns, Seymour Katz, Burton I. Korelitz and Miguel Regueiro and has published in prestigious journals such as Gastroenterology, Neurology and Gut.

In The Last Decade

Mark R. Fleisher

17 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

2008 592 citations William J. Sandborn, Brian G. Feagan et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark R. Fleisher United States	10	674	520	429	220	137	17	1.2k
Matthias Jürgens Germany	11	630 0.9×	443 0.9×	391 0.9×	162 0.7×	87 0.6×	19	884
Clare A. Pipkin United States	6	496 0.7×	463 0.9×	121 0.3×	108 0.5×	77 0.6×	8	728
Colleen McElree United States	10	1.1k 1.6×	518 1.0×	545 1.3×	491 2.2×	87 0.6×	11	1.5k
Spyros I. Siakavellas Greece	21	336 0.5×	435 0.8×	358 0.8×	226 1.0×	43 0.3×	48	993
Amy Marren United States	10	589 0.9×	328 0.6×	331 0.8×	209 0.9×	34 0.2×	26	919
Yoav Mazor Israel	17	610 0.9×	521 1.0×	300 0.7×	259 1.2×	39 0.3×	48	1.0k
Hanzhe Zheng United States	6	717 1.1×	572 1.1×	214 0.5×	187 0.8×	72 0.5×	13	895
J van der Woude Netherlands	7	459 0.7×	315 0.6×	340 0.8×	255 1.2×	22 0.2×	21	804
Yinghua Lang United States	9	1.2k 1.8×	974 1.9×	303 0.7×	431 2.0×	29 0.2×	15	1.4k
Filip J. Baert Belgium	12	461 0.7×	340 0.7×	204 0.5×	184 0.8×	37 0.3×	35	704

Countries citing papers authored by Mark R. Fleisher

Since Specialization

Citations

This map shows the geographic impact of Mark R. Fleisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Fleisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Fleisher more than expected).

Fields of papers citing papers by Mark R. Fleisher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Fleisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Fleisher. The network helps show where Mark R. Fleisher may publish in the future.

Co-authorship network of co-authors of Mark R. Fleisher

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Fleisher. A scholar is included among the top collaborators of Mark R. Fleisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Fleisher. Mark R. Fleisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

D’Haens, Geert, Jakob Benedict Seidelin, Andreas Lügering, et al.. (2023). Tu1705 DELAYED CLINICAL RESPONSE IN PATIENTS WITH CROHN'S DISEASE RECEIVING UPADACITINIB THERAPY. Gastroenterology. 164(6). S–1085. 2 indexed citations

Cash, Brooks D., Mark R. Fleisher, Elizabeth Rajan, et al.. (2020). Multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study). Gut. 70(11). 2115–2122. 44 indexed citations

Bruining, David H., Salvatore Oliva, Mark R. Fleisher, Monika Fischer, & Joel G. Fletcher. (2020). Panenteric capsule endoscopy versus ileocolonoscopy plus magnetic resonance enterography in Crohn’s disease: a multicentre, prospective study. BMJ Open Gastroenterology. 7(1). e000365–e000365. 45 indexed citations

Cash, Brooks D., Mark R. Fleisher, Elizabeth Rajan, et al.. (2019). 479 A MULTICENTER, PROSPECTIVE, RANDOMIZED STUDY COMPARING THE DIAGNOSTIC YIELD OF COLON CAPSULE ENDOSCOPY VERSUS COMPUTED TOMOGRAPHIC COLONOGRAPHY IN A SCREENING POPULATION. RESULTS OF THE TOPAZ STUDY. Gastrointestinal Endoscopy. 89(6). AB87–AB88. 7 indexed citations

Fleisher, Mark R., Jan Marsal, Scott D. Lee, et al.. (2018). Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease. Digestive Diseases and Sciences. 63(4). 825–833. 56 indexed citations

Melmed, Gil, Marla C. Dubinsky, David T. Rubin, et al.. (2018). Utility of video capsule endoscopy for longitudinal monitoring of Crohn’s disease activity in the small bowel: a prospective study. Gastrointestinal Endoscopy. 88(6). 947–955.e2. 32 indexed citations

Melmed, Gil, Marla Dubinsky, David T. Rubin, et al.. (2017). Longitudinal Evaluation with Capsule Endoscopy for Disease Monitoring of Patients with Crohn's Disease is Feasible, Valid, and Safe. Gastroenterology. 152(5). S770–S771. 1 indexed citations

Melmed, Gil, Marla Dubinsky, David T. Rubin, et al.. (2016). Tu1984 Utility of Capsule Endoscopy for Monitoring Crohn's Disease Activity. Gastroenterology. 150(4). S997–S997. 1 indexed citations

Sandborn, William J., Brian G. Feagan, Richard N. Fedorak, et al.. (2008). A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease. Gastroenterology. 135(4). 1130–1141. 592 indexed citations breakdown →

10.

Feagan, B G, Richard N. Fedorak, Ellen Scherl, et al.. (2008). A multicenter, randomized, phase 2A study of human monoclonal antibody to IL-12/23P40 (CNTO 1275) in patients with moderately to severely active Crohnʼs disease. Inflammatory Bowel Diseases. 14. S10–S10. 6 indexed citations

11.

Regueiro, Miguel, John F. Valentine, Scott E. Plevy, Mark R. Fleisher, & Gary R. Lichtenstein. (2003). Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. The American Journal of Gastroenterology. 98(8). 1821–1826. 155 indexed citations

12.

Korelitz, Burton I., et al.. (2003). Cumulative Experience With Short- and Long-Term Toxicity to 6-Mercaptopurine in the Treatment of Crohn's Disease and Ulcerative Colitis. Journal of Clinical Gastroenterology. 37(3). 220–225. 67 indexed citations

13.

Fleisher, Mark R.. (2002). Infliximab in the treatment of IBD-associated psoriasis and psoriasis-associated IBD. The American Journal of Gastroenterology. 97(9). S266–S266. 1 indexed citations

14.

Fleisher, Mark R., et al.. (2001). Remicade in the treatment of refractory extraintestinal manifestations of Crohn's disease. Gastroenterology. 120(5). A620–A620. 2 indexed citations

15.

Korelitz, Burton I., et al.. (1999). Malignant Neoplasms Subsequent to Treatment of Inflammatory Bowel Disease With 6-Mercaptopurine. The American Journal of Gastroenterology. 94(11). 3248–3253. 102 indexed citations

16.

Zlatanic, Jusuf, et al.. (1996). Crohn's disease and acute leukocytoclastic vasculitis of skin.. PubMed. 91(11). 2410–3. 26 indexed citations

17.

Brew, Bruce J., Mark R. Fleisher, M. Paul, et al.. (1989). Cerebrospinal fluid ß ₂ microglobulin in patients infected with human immunodeficiency virus. Neurology. 39(6). 830–830. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact